Elevated levels of Hcy are associated with increased levels of cardiovascular inflammation.
A trial of a gluten-free diet presents no inherent risk for patients starting to exhibit microvascular damage.
Vitamin D is often recognized for its impact on bone metabolism, but it is also an important regulator of immune function.
For years, dietary recommendations have focused on reducing saturated fat and its potential sources.
Elevated uric acid levels are associated with increased risks for hypertension, gout, and renal impairment.
The Mediterranean diet is getting more attention because of its long-term benefits in terms of overall mortality and CVD risk.
The benefits of omega-3 (n-3) fatty acids in renal populations were last discussed in this column in 2007.
Zinc supplementation has been shown to decrease levels of plasma aluminum and reactive oxygen species in dialysis patients.
Ghrelin is metabolized by the kidney; thus serum levels are elevated in chronic kidney disease populations.
Questions have been raised as to whether leptin has an impact on malnutrition in this population.
Foods that may increase gout flare risk are also dietary factors that may promote further kidney decline in individuals with CKD stages 3-5.
Dyslipidemia often is a concern in patients with CKD because mortality in this population typically is the result of cardiovascular complications.
Age and physical activity have profound effects on the accrual and retention of lean body tissues, but a range of nutritional factors can influence this process.
Testosterone deficiency is common in many patients with CKD, but the treatment of this deficiency and associated side effects have not always received much attention.
Metabolic acidosis is a typical concern in renal populations, including renal transplant recipients (RTRs).